COLES N ANTHONY 1197018 Data last updated 2024-05-14 07:02:16 -0500 US CDT
Latest Holdings
Notice: Data summarized from Form 3,4,5 filings, which do not include holdings/transactions of investment institution(s), if any, managed by the reporter.
Non-derivative Transactions CSV download
Tips: type "code_s" to show transactions with code "S".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-05-08 | 2023-05-04 | 2023-05-04 | 4 | Coles N Anthony | CEO AND CHAIRPERSON | acq | 50000.0 | 94.87 | 3.19 | 3.5 | Direct | Common Stock | CEREVEL THERAPEUTICS HOLDINGS, INC. | code M | 52704.0 | 156.83 (CERE) |
| 2023-05-08 | 2023-05-04 | 2023-05-04 | 4 | Coles N Anthony | CEO AND CHAIRPERSON | dsp | 50000.0 | 94.87 | 3.19 | 31.47 | Direct | Common Stock | CEREVEL THERAPEUTICS HOLDINGS, INC. | code S | 2704.0
|
156.83 (CERE) |
| 2023-06-05 | 2023-06-01 | 2023-06-01 | 4 | Coles N Anthony | CEO AND CHAIRPERSON | acq | 50000.0 | 94.87 | 3.19 | 3.5 | Direct | Common Stock | CEREVEL THERAPEUTICS HOLDINGS, INC. | code M | 52704.0 | 156.83 (CERE) |
| 2023-06-05 | 2023-06-01 | 2023-06-01 | 4 | Coles N Anthony | CEO AND CHAIRPERSON | dsp | 50000.0 | 94.87 | 3.19 | 32.6 | Direct | Common Stock | CEREVEL THERAPEUTICS HOLDINGS, INC. | code S | 2704.0 | 156.83 (CERE) |
| 2023-07-13 | 2023-07-11 | 2023-07-11 | 4 | Coles N Anthony | DIRECTOR | acq | 50000.0 | 94.87 | 3.19 | 3.5 | Direct | Common Stock | CEREVEL THERAPEUTICS HOLDINGS, INC. | code M | 52704.0 | 156.83 (CERE) |
| 2023-07-13 | 2023-07-11 | 2023-07-11 | 4 | Coles N Anthony | DIRECTOR | dsp | 50000.0 | 94.87 | 3.19 | 30.03 | Direct | Common Stock | CEREVEL THERAPEUTICS HOLDINGS, INC. | code S | 2704.0 | 156.83 (CERE) |
| 2023-09-08 | 2023-09-07 | 2023-09-07 | 4 | Coles N Anthony | DIRECTOR | acq | 50000.0 | 94.87 | 3.17 | 3.5 | Direct | Common Stock | CEREVEL THERAPEUTICS HOLDINGS, INC. | code M | 52704.0 | 157.49 (CERE) |
| 2023-09-08 | 2023-09-07 | 2023-09-07 | 4 | Coles N Anthony | DIRECTOR | dsp | 50000.0 | 94.87 | 3.17 | 24.07 | Direct | Common Stock | CEREVEL THERAPEUTICS HOLDINGS, INC. | code S | 2704.0 | 157.49 (CERE) |
| 2023-11-06 | 2023-11-02 | 2023-11-02 to 2023-11-03 | 4 | Coles N Anthony | DIRECTOR | acq | 100000.0 | 100 | 5.55 | 3.5 | Direct | Common Stock | CEREVEL THERAPEUTICS HOLDINGS, INC. | code M | 64105.0
|
180.28 (CERE) |
| 2023-11-06 | 2023-11-02 | 2023-11-02 to 2023-11-03 | 4 | Coles N Anthony | DIRECTOR | dsp | 100000.0 | 97.37 | 5.55 | 25.34 | Direct | Common Stock | CEREVEL THERAPEUTICS HOLDINGS, INC. | code S | 2704.0
|
180.28 (CERE) |
| 2023-11-09 | 2023-11-07 | 2023-11-07 to 2023-11-08 | 4 | Coles N Anthony | DIRECTOR | acq | 27176.0 | 100 | 1.51 | 3.5 | Direct | Common Stock | CEREVEL THERAPEUTICS HOLDINGS, INC. | code M | 2804.0
|
180.28 (CERE) |
| 2023-11-09 | 2023-11-07 | 2023-11-07 to 2023-11-08 | 4 | Coles N Anthony | DIRECTOR | dsp | 27176.0 | 90.95 | 1.51 | 25.02 | Direct | Common Stock | CEREVEL THERAPEUTICS HOLDINGS, INC. | code S | 2704.0
|
180.28 (CERE) |
| 2023-11-16 | 2023-11-14 | 2023-11-14 | 4 | Coles N Anthony | DIRECTOR | dsp | 22824.0 | 89.41 | 1.27 | 25.13 | Direct | Common Stock | CEREVEL THERAPEUTICS HOLDINGS, INC. | code S | 2704.0 | 180.28 (CERE) |
| 2023-11-16 | 2023-11-14 | 2023-11-14 | 4 | Coles N Anthony | DIRECTOR | acq | 22824.0 | 89.41 | 1.27 | 3.5 | Direct | Common Stock | CEREVEL THERAPEUTICS HOLDINGS, INC. | code M | 25528.0 | 180.28 (CERE) |
| 2024-01-04 | 2024-01-02 | 2024-01-02 | 4 | Coles N Anthony | DIRECTOR | acq | 135.0 | 9.69 | 0.01 | 0.0 | Direct | Common Stock | REGENERON PHARMACEUTICALS, INC. | code A | 1393.0 | 107.13 (REGN) |
| 2024-01-04 | 2024-01-02 | 2024-01-02 | 4 | Coles N Anthony | DIRECTOR | dsp | 50000.0 | 94.87 | 2.77 | 42.24 | Direct | Common Stock | CEREVEL THERAPEUTICS HOLDINGS, INC. | code S | 2704.0 | 180.28 (CERE) |
| 2024-01-04 | 2024-01-02 | 2024-01-02 | 4 | Coles N Anthony | DIRECTOR | acq | 50000.0 | 94.87 | 2.77 | 3.5 | Direct | Common Stock | CEREVEL THERAPEUTICS HOLDINGS, INC. | code M | 52704.0 | 180.28 (CERE) |
| 2024-02-08 | 2024-02-06 | 2024-02-06 | 4 | Coles N Anthony | DIRECTOR | acq | 15440.0 | 85.1 | 0.86 | 0.0 | Direct | Common Stock | CEREVEL THERAPEUTICS HOLDINGS, INC. | code M | 18144.0 | 180.28 (CERE) |
| 2024-02-08 | 2024-02-06 | 2024-02-07 | 4 | Coles N Anthony | DIRECTOR | dsp | 2506.0 | 13.81 | 0.14 | 41.54 | Direct | Common Stock | CEREVEL THERAPEUTICS HOLDINGS, INC. | code S | 15638.0 | 180.28 (CERE) |
| 2024-03-04 | 2024-02-29 | 2024-02-29 | 4 | Coles N Anthony | DIRECTOR | acq | 50000.0 | 76.18 | 2.77 | 3.5 | Direct | Common Stock | CEREVEL THERAPEUTICS HOLDINGS, INC. | code M | 65638.0 | 180.28 (CERE) |
| 2024-03-04 | 2024-02-29 | 2024-02-29 | 4 | Coles N Anthony | DIRECTOR | dsp | 50000.0 | 76.18 | 2.77 | 41.16 | Direct | Common Stock | CEREVEL THERAPEUTICS HOLDINGS, INC. | code S | 15638.0 | 180.28 (CERE) |
| 2024-03-06 | 2024-03-04 | 2024-03-04 | 4 | Coles N Anthony | DIRECTOR | dsp | 50000.0 | 76.18 | 2.77 | 41.01 | Direct | Common Stock | CEREVEL THERAPEUTICS HOLDINGS, INC. | code S | 15638.0 | 180.28 (CERE) |
| 2024-03-06 | 2024-03-04 | 2024-03-04 | 4 | Coles N Anthony | DIRECTOR | acq | 50000.0 | 76.18 | 2.77 | 3.5 | Direct | Common Stock | CEREVEL THERAPEUTICS HOLDINGS, INC. | code M | 65638.0 | 180.28 (CERE) |
| 2024-04-03 | 2024-04-01 | 2024-04-01 | 4 | Coles N Anthony | DIRECTOR | acq | 50000.0 | 76.18 | 2.77 | 3.5 | Direct | Common Stock | CEREVEL THERAPEUTICS HOLDINGS, INC. | code M | 65638.0 | 180.28 (CERE) |
| 2024-04-03 | 2024-04-01 | 2024-04-01 | 4 | Coles N Anthony | DIRECTOR | dsp | 50000.0 | 76.18 | 2.77 | 42.33 | Direct | Common Stock | CEREVEL THERAPEUTICS HOLDINGS, INC. | code S | 15638.0 | 180.28 (CERE) |
Derivative Transactions
Tips: type "code_m" to show transactions with code "M".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-05-08 | 2023-05-04 | 2023-05-04 | 4 | Coles N Anthony | CEO AND CHAIRPERSON | dsp | 50000.0 | 1.75 | 3.19 | 3.5 | Direct | Stock Option (Right To Buy) | CEREVEL THERAPEUTICS HOLDINGS, INC. | code M | 2802417.0 | 156.83 (CERE) |
| 2023-06-05 | 2023-06-01 | 2023-06-01 | 4 | Coles N Anthony | CEO AND CHAIRPERSON | dsp | 50000.0 | 1.78 | 3.19 | 3.5 | Direct | Stock Option (Right To Buy) | CEREVEL THERAPEUTICS HOLDINGS, INC. | code M | 2752417.0 | 156.83 (CERE) |
| 2023-07-13 | 2023-07-11 | 2023-07-11 | 4 | Coles N Anthony | DIRECTOR | dsp | 50000.0 | 1.82 | 3.19 | 3.5 | Direct | Stock Option (Right To Buy) | CEREVEL THERAPEUTICS HOLDINGS, INC. | code M | 2702417.0 | 156.83 (CERE) |
| 2023-09-08 | 2023-09-07 | 2023-09-07 | 4 | Coles N Anthony | DIRECTOR | dsp | 50000.0 | 1.85 | 3.17 | 3.5 | Direct | Stock Option (Right To Buy) | CEREVEL THERAPEUTICS HOLDINGS, INC. | code M | 2652417.0 | 157.49 (CERE) |
| 2023-11-06 | 2023-11-02 | 2023-11-02 to 2023-11-03 | 4 | Coles N Anthony | DIRECTOR | dsp | 100000.0 | 3.77 | 5.55 | 3.5 | Direct | Stock Option (Right To Buy) | CEREVEL THERAPEUTICS HOLDINGS, INC. | code M | 2552417.0
|
180.28 (CERE) |
| 2023-11-09 | 2023-11-07 | 2023-11-07 to 2023-11-08 | 4 | Coles N Anthony | DIRECTOR | dsp | 27176.0 | 1.06 | 1.51 | 3.5 | Direct | Stock Option (Right To Buy) | CEREVEL THERAPEUTICS HOLDINGS, INC. | code M | 2525241.0
|
180.28 (CERE) |
| 2023-11-16 | 2023-11-14 | 2023-11-14 | 4 | Coles N Anthony | DIRECTOR | dsp | 22824.0 | 0.9 | 1.27 | 3.5 | Direct | Stock Option (Right To Buy) | CEREVEL THERAPEUTICS HOLDINGS, INC. | code M | 2502417.0 | 180.28 (CERE) |
| 2024-01-04 | 2024-01-02 | 2024-01-02 | 4 | Coles N Anthony | DIRECTOR | acq | 1607.0 | 100.0 | 0.15 | 888.34 | Direct | Non Qualified Stock Option (Right To Buy) | REGENERON PHARMACEUTICALS, INC. | code A | 1607.0 | 107.13 (REGN) |
| 2024-01-04 | 2024-01-02 | 2024-01-02 | 4 | Coles N Anthony | DIRECTOR | dsp | 50000.0 | 2.0 | 2.77 | 3.5 | Direct | Stock Option (Right To Buy) | CEREVEL THERAPEUTICS HOLDINGS, INC. | code M | 2452417.0 | 180.28 (CERE) |
| 2024-02-08 | 2024-02-06 | 2024-02-06 | 4 | Coles N Anthony | DIRECTOR | dsp | 15440.0 | 25.0 | 0.86 | 0.0 | Direct | Restricted Stock Units | CEREVEL THERAPEUTICS HOLDINGS, INC. | code M | 46322.0 | 180.28 (CERE) |
| 2024-03-04 | 2024-02-29 | 2024-02-29 | 4 | Coles N Anthony | DIRECTOR | dsp | 50000.0 | 2.04 | 2.77 | 3.5 | Direct | Stock Option (Right To Buy) | CEREVEL THERAPEUTICS HOLDINGS, INC. | code M | 2402417.0 | 180.28 (CERE) |
| 2024-03-06 | 2024-03-04 | 2024-03-04 | 4 | Coles N Anthony | DIRECTOR | dsp | 50000.0 | 2.08 | 2.77 | 3.5 | Direct | Stock Option (Right To Buy) | CEREVEL THERAPEUTICS HOLDINGS, INC. | code M | 2352417.0 | 180.28 (CERE) |
| 2024-04-03 | 2024-04-01 | 2024-04-01 | 4 | Coles N Anthony | DIRECTOR | dsp | 50000.0 | 2.13 | 2.77 | 3.5 | Direct | Stock Option (Right To Buy) | CEREVEL THERAPEUTICS HOLDINGS, INC. | code M | 2302417.0 | 180.28 (CERE) |
a Sum of same type of securities in the form
b Relative to reporter's shares owned before (disposition) or after (acquisition) operation
c Relative to issuer's shares outstanding (1/10000)
d Average price for securities of the same type. Check the original form for detailed prices of multiple transactions
e Documented shares outstanding closest to the transaction date
Note: Corporate may change mapped CIK when merge or spin-off happen. Please report error if the ticker you searched for does not have up-to-date insider trading information.
Show up to records per table for current tier. Access Guide)